Sonnet BioTherapeutics has received a patent from the European Patent Office (EPO) for its fully human albumin binding (FHAB) ...
A proposed ban on PFAS chemicals is being challenged over concerns about potential supply chain disruption in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback